Halo Labs Inc. HALO AGEEF agreed to acquire all of Precisa Medical Instruments Corp.'s common shares for CA$3.75 million, at a price of 28 cents a share.
Halo plans to fund the Prescia-owned vape product Accu-Dab by investing $1.2 million.
A wholly owned subsidiary, Halo Accu-Dab Holdings Inc., plans to acquire all of Prescia's common shares, giving the company a total of 13,392,857. Prescia will fall under the Halo umbrella as a subsidiary of the wholly owned subsidiary.
"Now, we are developing the Accu-Dab to allow more generalized consumption through sublingual application of CBD and THC for those who are averse to vaporizing and want a discrete and accurate consumption method," Halo CEO and Co-founder Kiran Sidhu said in a statement.
The purchase and concurrent funding are slated to close in early January.
Related Links:
Halo Labs' Q3 Revenue Jumps 99% Year-Over-Year
Bulls And Bud Of The Week: Halo Labs And 6 Things To Do In Illinois When Cannabis Becomes Legal
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
